Skip to main content
. 2023 Apr 14;91:104559. doi: 10.1016/j.ebiom.2023.104559

Fig. 2.

Fig. 2

Frequency of 3CLpro mutations (sequences per million) among sequences deposited onto GISAID up to 14th December 2022. Only the 10 most frequently found mutations affecting the inhibitory activity of nirmatrelvir or ensitrelvir are shown.